Holmusk is a digital health and data analytics company focused on solving complex problems in healthcare.
Holmusk leverages technology and data science to accelerate research and improve outcomes for people with chronic diseases and behavioral health disorders.
Holmusk was founded in 2015 by Nawal Roy. The company is based in Singapore, with additional offices in the US (New York, North Carolina), UK (London), and Malaysia, and will be opening an office in China (Shanghai) in 2019.
Holmusk's proprietary modeling platform leverages scientific research and digital healthcare data to inform predictive algorithms and provide actionable insights for personalized medicineproprietary modeling platform leverages scientific research and digital healthcare data to inform predictive algorithms and provide actionable insights for personalized medicine
Holmusk also builds innovative, scalable and cost-effective digital behavior change programs that combine cutting-edge clinical research, technology and design to nudge people towards sustainable changes for better health.
Holmusk's flagship behavior change program is GlycoLeap, a smart coach for Type 2 diabetes. Beautifully designed, simple to use and convenient.
Holmusk is backed by Capikris Foundation, Optum Ventures (OV), Health Catalyst Capital (HCC), Heritas Venture Fund, and Slush Singapore X Philips Startup Challenge. The company raised $21.5M in a Series A round on May 18, 2020. This brings Holmusk's total funding to $31.25M to date.